Lite Strategy, Inc. Increase (Decrease) in Deferred Revenue
Lite Strategy, Inc. (LITS) reported Increase (Decrease) in Deferred Revenue of -$48.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-11-08
- Lite Strategy, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was -$48.00K.
- Lite Strategy, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$55.00K.
- Lite Strategy, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$47.00K.
- Lite Strategy, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$57.00K.
- Lite Strategy, Inc. increase (decrease) in deferred revenue for fiscal 2018 was -$208.00K, a 120.88% decline from fiscal 2017.
- Lite Strategy, Inc. increase (decrease) in deferred revenue for fiscal 2017 was $996.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$48.00K 10-Q · filed 2018-11-08 | -$103.00K derived: sum of 2 quarters · filed 2018-11-08 | -$150.00K derived: sum of 3 quarters · filed 2018-11-08 | -$207.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-30 | -$102.00K derived: sum of 2 quarters · filed 2018-08-30 | -$159.00K derived: sum of 3 quarters · filed 2018-08-30 | -$208.00K 10-K · filed 2018-08-30 |
| 2018-03-31 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | -$104.00K derived: sum of 2 quarters · filed 2018-05-09 | -$153.00K 10-Q · filed 2018-05-09 | -$193.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-12-31 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | -$106.00K 10-Q · filed 2018-02-08 | -$146.00K derived: sum of 3 quarters · filed 2018-11-08 | |
| 2017-09-30 | -$49.00K 10-Q · filed 2018-11-08 | -$89.00K derived: sum of 2 quarters · filed 2018-11-08 | ||
| 2017-06-30 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-30 | $996.00K 10-K · filed 2018-08-30 | ||
| 2017-03-31 | $1.04M 10-Q · filed 2018-05-09 | |||
| 2016-09-30 | $15.54M 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |